November 2025 in “Undersea and Hyperbaric Medicine” Medical ozone therapy can cause serious complications, but hyperbaric oxygen therapy can help treat these issues.
November 2023 in “Journal of the American Academy of Dermatology” August 2023 in “Journal of The American Academy of Dermatology” July 2023 in “JAAD Case Reports” January 2023 in “Journal of the American Academy of Dermatology” October 2020 in “Journal of the American Academy of Dermatology” June 2020 in “Journal of the American Academy of Dermatology” August 2018 in “Journal of Investigative Dermatology”
February 2014 in “Journal of The American Academy of Dermatology”
February 2012 in “Journal of The American Academy of Dermatology”
September 1996 in “Journal of the American Academy of Dermatology” July 2024 in “Journal of the American Academy of Dermatology”
3 citations
,
August 2017 in “International journal of reproduction, contraception, obstetrics and gynecology” People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.
1 citations
,
December 2020 in “Journal of diabetes and endocrine practice” I'm sorry, but I can't provide a summary without the content of the document.
May 2019 in “Journal of Evidence Based Medicine and Healthcare” Alopecia Areata is often linked to other health issues like allergies, thyroid problems, and diabetes.
5-ARI therapy may help prevent prostate cancer progression.
July 2024 in “International Society of Hair Restoration Surgery”
January 2023 in “Editora Enterprising eBooks” The document's conclusion cannot be provided because the document cannot be parsed.
12 citations
,
January 2004 in “International Journal of aromatherapy/International journal of aromatherapy” Ocimum oil may promote hair growth and reduce hair loss from cyclophosphamide.
2 citations
,
March 2025 in “JAMA Dermatology” High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.
July 2025 in “American Journal on Addictions” Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.
1 citations
,
November 2024 in “Expert Opinion on Drug Safety” This study analyzed 7,933 adverse event reports related to aromatase inhibitors (AIs) from the FDA Adverse Event Reporting System, covering data from 2004 to 2023. It identified 642 positive signals of adverse reactions, with specific concerns for each AI: anastrozole was linked to antiphospholipid syndrome, plantar fasciitis, and autoimmune pancreatitis; letrozole was associated with androgenetic alopecia, myosclerosis, and pneumonic herpes virus; exemestane was connected to infection reactivation, decreased thyroxine free, and atrial dilatation. Letrozole had the earliest onset of adverse events, followed by exemestane and anastrozole. The study underscores the importance of monitoring these adverse events in real-world clinical settings.
15 citations
,
January 2011 in “Annals of Dermatology” The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.
27 citations
,
May 2011 in “Current Opinion in Ophthalmology” New treatments using stem cells and special materials show promise for severe eye surface disease.
Onychomatricoma is a unique nail tumor, not related to other hair-related tumors.
November 2024 in “Burns & Trauma” Skin organoids help improve wound healing and tissue repair.
June 2023 in “British Journal of Dermatology” The prototype for analyzing skin aging works technically and clinically.
2 citations
,
August 2018 in “Korean Journal of Plant Resources” Oregonin from Alnus japonica may help prevent hair loss and promote hair growth.